These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23292145)

  • 1. The role of peptide YY in gastrointestinal diseases and disorders (review).
    El-Salhy M; Mazzawi T; Gundersen D; Hatlebakk JG; Hausken T
    Int J Mol Med; 2013 Feb; 31(2):275-82. PubMed ID: 23292145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide YY in gastrointestinal disorders.
    El-Salhy M; Suhr O; Danielsson A
    Peptides; 2002 Feb; 23(2):397-402. PubMed ID: 11825655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide YY and appetite control.
    McGowan BM; Bloom SR
    Curr Opin Pharmacol; 2004 Dec; 4(6):583-8. PubMed ID: 15525548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide YY(1-36) and peptide YY(3-36): Part I. Distribution, release and actions.
    Ballantyne GH
    Obes Surg; 2006 May; 16(5):651-8. PubMed ID: 16687037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS).
    El-Salhy M; Hatlebakk JG; Hausken T
    Neuropeptides; 2020 Feb; 79():101973. PubMed ID: 31727345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YY.
    Schmidt PT; Ljung T; Hartmann B; Hare KJ; Holst JJ; Hellström PM
    Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):207-12. PubMed ID: 15674099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous peptide YY and neuropeptide Y inhibit colonic ion transport, contractility and transit differentially via Y₁ and Y₂ receptors.
    Tough IR; Forbes S; Tolhurst R; Ellis M; Herzog H; Bornstein JC; Cox HM
    Br J Pharmacol; 2011 Sep; 164(2b):471-84. PubMed ID: 21457230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide YY(1-36) and peptide YY(3-36): Part II. Changes after gastrointestinal surgery and bariatric surgery.
    Ballantyne GH
    Obes Surg; 2006 Jun; 16(6):795-803. PubMed ID: 16756746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pinealectomy and exogenous melatonin on ghrelin and peptide YY in gastrointestinal system and neuropeptide Y in hypothalamic arcuate nucleus: immunohistochemical studies in male rats.
    Aydin M; Canpolat S; Kuloğlu T; Yasar A; Colakoglu N; Kelestimur H
    Regul Pept; 2008 Feb; 146(1-3):197-203. PubMed ID: 17936373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide YY regulates bone remodeling in mice: a link between gut and skeletal biology.
    Wong IP; Driessler F; Khor EC; Shi YC; Hörmer B; Nguyen AD; Enriquez RF; Eisman JA; Sainsbury A; Herzog H; Baldock PA
    PLoS One; 2012; 7(7):e40038. PubMed ID: 22792209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic approaches towards the treatment of gastroinstestinal disorders.
    Collingwood S; Witherington J
    Drug News Perspect; 2007 Mar; 20(2):139-44. PubMed ID: 17440638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry-assisted confirmation of the inability of dipeptidyl peptidase-4 to cleave goldfish peptide YY(1-36) and the lack of anorexigenic effects of peptide YY(3-36) in goldfish (Carassius auratus).
    Gonzalez R; Unniappan S
    Fish Physiol Biochem; 2016 Jun; 42(3):831-44. PubMed ID: 26676513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Neuropeptide Y and Peptide YY in the Development of Obesity via Gut-brain Axis.
    Wu Y; He H; Cheng Z; Bai Y; Ma X
    Curr Protein Pept Sci; 2019; 20(7):750-758. PubMed ID: 30678628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging therapeutic potential for peptide YY for obesity-diabetes.
    Lafferty RA; Flatt PR; Irwin N
    Peptides; 2018 Feb; 100():269-274. PubMed ID: 29412828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide YY abnormalities in gastrointestinal diseases.
    Adrian TE; Savage AP; Bacarese-Hamilton AJ; Wolfe K; Besterman HS; Bloom SR
    Gastroenterology; 1986 Feb; 90(2):379-84. PubMed ID: 3753594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide YY: a neuroendocrine neighbor of note.
    Cox HM
    Peptides; 2007 Feb; 28(2):345-51. PubMed ID: 17194503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of oxyntomodulin and peptide tyrosine-tyrosine (PYY) in appetite control.
    Wynne K; Bloom SR
    Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):612-20. PubMed ID: 17082808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulatory actions of insulin-like growth factor-I and transforming growth factor-alpha on intestinal neurotensin and peptide YY.
    Lee HM; Udupi V; Englander EW; Rajaraman S; Coffey RJ; Greeley GH
    Endocrinology; 1999 Sep; 140(9):4065-9. PubMed ID: 10465277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tachykinins: role in human gastrointestinal tract physiology and pathology.
    Improta G; Broccardo M
    Curr Drug Targets; 2006 Aug; 7(8):1021-9. PubMed ID: 16918330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome.
    El-Salhy M; Gundersen D; Ostgaard H; Lomholt-Beck B; Hatlebakk JG; Hausken T
    Dig Dis Sci; 2012 Apr; 57(4):873-8. PubMed ID: 22057239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.